Abstract
Dental caries and trauma always lead to pulp necrosis and subsequent root development arrest of young permanent teeth. The traditional treatment, apexification, with the absence of further root formation, results in abnormal root morphology and compromises long-term prognosis. Regeneration endodontics procedures (REPs) have been developed and considered as an alternative strategy for management of immature permanent teeth with pulpal necrosis, including cell-free and cell-based REPs. Cell-free REPs, including revascularization and cell homing with molecules recruiting endogenous mesenchymal stem cells (MSCs), have been widely applied in clinical treatment, showing optimistic periapical lesion healing and continued root development. However, the regenerated pulp–dentin complex is still absent in these cases. Dental MSCs, as one of the essentials of tissue engineering, are vital seed cells in regenerative medicine. Dental MSC–based REPs have presented promising potential with pulp–dentin regeneration in large animal studies and clinical trials via cell transplantation. In the present review, we summarize current understanding of the biological basis of clinical treatments for immature necrotic permanent teeth and the roles of dental MSCs during this process and update the progress of MSC-based REPs in the administration of immature necrotic permanent teeth.
Introduction
Immature permanent teeth are prone to pulpal necrosis due to caries, trauma, or developmental malformation. These cases always lead to arrest of root formation, accompanied by thin root dentinal walls and open apices, which has been a challenge in endodontics (Shabahang, 2012). With apexification, the traditional treatment, either calcium hydroxide or mineral trioxide aggregate (MTA) is applied to achieve apical sealing (; ). Apexification has been reported to resolve apical periodontitis with a success rate of 74–100% (). However, absence of further root formation with apexification still results in abnormal root morphology, such as thin dentinal walls with an increased risk of root fracture, consequently compromising long-term prognosis ().
Regeneration endodontics procedures (REPs) have been developed and considered as an alternative strategy for treatment of immature permanent teeth with pulp necrosis (). The notion of tissue regeneration in the root canal was first proposed in the 1960s (). introduced a case report describing an alternative treatment for the management of necrotic immature permanent teeth called revascularization, in which a blood clot was induced inside the root canal after control of inflammation. Later, autologous platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) took the place of the blood clot as alternative scaffolds because of their potential to induce tissue regeneration (). A standard protocol for clinical REPs was proposed by the ) in 2016 These REPs without exogenous cells, including revascularization and cell homing, have been successful in resolving apical periodontitis and arrest of root formation (; Torabinejad and Turman, 2010; Shimizu et al., 2013). However, histological studies show that the pulp–dentin complex is absent in these cases although some of them have shown vital pulp (Shimizu et al., 2013; Ulusoy et al., 2019). Desired REPs are supposed to eliminate apical periodontitis; increase root length, dentinal wall thickness, and apical closure; and restore homeostatic function of the pulp–dentin complex, including inherent immunity, tertiary dentin formation with stimulus, and pulp sensibility. In particular, the reinstitution of pulp–dentin structure functions prolongs the life of the tooth. Hence, scientists and endodontists are keen to develop a novel regenerative strategy to achieve pulp vitality and organized pulp–dentin structure with homeostatic functions.
Three major elements have been recommended by Diogenes for further studies of pulp–dentin regeneration, including (i) reliable cell resources responsible for formation of root dentin, pulp tissue, and supporting tissue; (ii) an applicable scaffold to facilitate cellular proliferation and differentiation; and (iii) signaling molecules to motivate and direct tissue development, maturation, and neovascularization (). Mesenchymal stem cells (MSCs) responsible for pulp–dentin regeneration might be indispensable for ideal REPs. Several preclinical studies reveal the regenerative potential of pulp–dentin tissue via cultured cell transplantation (; ; Xuan et al., 2018). With its accessibility and unique potential in dental tissue regeneration, including the pulp–dentin complex, dental MSCs play a decisive role of seed cells in REPs. In this context, the applications of dental pulp stem cells (DPSCs), stem cells from human exfoliated deciduous teeth (SHED), stem cells from apical papilla (SCAP), periodontal ligament stem cells (PDLSCs), and dental follicle stem cells (DFSCs) have been explored. In the latest clinical study (Xuan et al., 2018), implantation of autologous SHED aggregates generated pulp–dentin complex in immature necrotic permanent incisors of pediatric patients, including functional dental pulp tissue regeneration with vasculature, innervation, and the lining odontoblast layer. The regenerated dental pulp tissue promotes root elongation and apical foramen closure. Therefore, dental MSCs exert therapeutic applications and are of great importance in treating immature necrotic permanent teeth.
In this review, we briefly summarize the current understanding of the biological basis of clinical treatments for immature permanent teeth with pulpal necrosis and the roles of dental MSCs during this process and update the progress of MSC-based REPs in the treatment of immature necrotic permanent teeth.
Biological Basis for REPs
Root development relies on temporospatial reciprocal action between dental epithelium (Hertwig’s epithelial root sheath, HERS) and mesenchyme from the cranial neural crest (dental papilla and follicle) (Thesleff and Sharpe, 1997). When the tooth crown is formed, HERS is formed by the inner and outer enamel epithelium of the enamel organ, which lies between the dental papilla and follicle. Then, HERS extends apically with the dental papilla and follicle and eventually regulates root formation. The inner epithelial cells of HERS induce MSCs at the periphery of the pulp to form odontoblasts, which produce the root dentin (). As SHED fragments, the dental follicle penetrates into the epithelial fenestrations, contacts the root dentin, and differentiates into cementoblasts, which form the cementum covering the root dentin (Zeichner-David et al., 2003; Sonoyama et al., 2007b; ). The dental follicle is also responsible for the formation of periodontal ligament and fiber bundles. Hence, HERS plays a vital role in the interaction between the dental epithelial and dental mesenchymal compartment during root formation (Figure 1).
FIGURE 1
Arrested root formation in immature necrotic permanent teeth is always related to severe HERS damage due to dental trauma (). Inflammatory cytokines and chemokines induced by severe and chronic inflammation impair the stem cells during tissue repair (). Additionally, function of SCAP could be disrupted by proinflammatory cytokines (; ; Wang et al., 2017). Hence, root formation is halted in immature permanent teeth with pulpal necrosis. Once inflammation is controlled, proinflammatory cytokine and chemokines are reduced, which leads to resumption of the regulatory effect of HERS and, consequently, induces the continued formation of the incomplete root (; ). MSCs are vulnerable to the inflammatory microenvironment, and their immunomodulatory capacities can vary unexpectedly with the exposure to different inflammatory conditions (). It is demonstrated that the TNFα/TNFR2 signaling pathway is involved in regulating the immunomodulatory properties of MSCs (, ). The TNFα–TNFR2 axis mediates MSCs’ anti-inflammatory effects and cell survival, indicated by the inhibition of T cell proliferation, the production of proinflammatory cytokines, and the inductive activation of regulatory T cells. The presence of the TNFR2 molecule is also involved in the regulatory effect of MSCs, such as the colony-forming unit, proliferation, and MSC-specific surface markers. TNFR2 is expressed predominantly in endothelial progenitor cells. The TNFα/TNFR2 signaling pathway is also critical in the regulation of endothelial progenitor cell immunosuppression and the angiogenic effect to form new immunosuppressive vessels (). Whether the inflammatory environment caused by pulpal necrosis/apical periodontitis plays protective and essential roles in the biological functions of SCAPs needs further study. A previous study suggests the long-term viability of apical papilla under prolonged root canal infection and apical periodontitis (). On the contrary, MSCs responsible for the pulp–dentin complex in the root canal rarely survive during chronic endodontic infection, which explains the absence of pulp–dentin regeneration with revascularization or cell homing.
Dental Mesenchymal Stem Cells
Human MSCs are multipotent cells from various tissues, such as skeletal muscle, adipose tissue, placenta, bone, and dental tissue (). Based on minimal criteria proposed by the International Society for Cellular Therapy (ISCT), MSCs are plastic-adherent; possess multilineage differentiation potential in vitro; express at least CD105, CD73, and CD90; and negatively express CD11b, CD14, CD19, CD34, CD45, CD79α, and HLA-DR cell surface markers (; ). According to MSC minimal criteria, dental MSCs derived from dental tissues, including impacted teeth and their supporting tissues, have been identified and characterized with typical MSC properties (Sharpe, 2016; Table 1). In addition to easy access, dental MSCs are genomically stable after multiple passages in vitro. Despite their multilineage differentiation capacity, dental MSCs are distinct from other MSCs because of the unique potential in dental tissue regeneration and have aroused much interest in regenerative medicine, especially the applications of REPs (). To date, dentin, dental pulp, or even pulp–dentin complex-like structure regenerations with the application of dental MSCs have been widely investigated, including DPSCs, SHED, SCAP, PDLSCs, and DFSCs.
TABLE 1
| Source | Surface marker positive | Surface marker negative | Multi-lineage differentiation potential | Immunomodulatory properties | |
| DPSCs | Dental pulp tissue of permanent teeth | CD9, CD10, CD13, CD29, CD44, CD59, CD73, CD90, CD105, CD106, CD146, CD166, STRO-1, NANOG, SOX2, OCT4, TRA1-60, TRA-1-80-1, and Nestin | CD14, CD19, CD24, CD31, CD34, CD45, and CD117 | odontoblasts, osteoblasts, chondrocytes, adipocytes, neurons, cardiomyocyte, and hepatocytes | Immunosuppressive properties increased HGF, TGF-β, PGE-2, IL-6, and IDO; decreased IL-4 and IFN-γ; suppressed proliferation of T cells and PBMCs; increased number of regulatory T cells |
| SHED | Dental pulp tissue of exfoliated deciduous teeth | CD13, CD29, CD44, CD73, CD90, CD105, CD146, STRO-1, NANOG, adn Nestin | CD14, CD15, CD19, CD34, and CD45 | odontoblasts, osteocytes, chondrocytes, adipocytes, neurons, and hepatocytes | Immunosuppressive properties increased IL-10; decreased IL-4 and IFN-γ; inhibited Th17 cell differentiation; increased number of regulatory T cells |
| SCAP | Apical papilla | CD13, CD24, CD29, CD44, CD49, CD51, CD56, CD61, CD73, CD90, CD106, CD146, CD166, STRO-1, NANOG, and Nestin | CD14, CD18, CD34, and CD45 | odontoblasts, osteocytes, adipocytes, neurons, and hepatocytes | Low immunogenicity inhibited proliferation of T cells |
| PDLSCs | Periodontal ligament | CD9, CD10, CD13, CD29, CD44, CD59, CD73, CD90, CD105 CD106, CD146, CD166, and STRO-1 | CD14, CD19, CD34, CD45, and HLA-DR | cementoblasts, osteoblasts, chondrocytes, adipocytes, and neurons | Immunosuppressive properties expressing TLR2 and TLR4; released HGF, TGF-β, and IDO; suppressed proliferation of PBMCs |
| DFSCs | Dental follicle | CD9, CD10, CD13, CD29, CD44, CD59, CD73, CD90, CD105, CD106, CD146, CD166, STRO-1, NANOG, SOX2, OCT4, and Nestin | CD31, CD34, CD45, and CD133 | odontoblasts, cementoblasts, osteoblasts, chondrocytes, adipocytes, neurons, and cardiomyocytes | Immunosuppressive properties expressing TLR2, TLR3, and TLR4; increased IL-6, TGF-β, and IDO-1; decreased IFN-γ, IL-4, and IL-8; suppressed proliferation and apoptosis of PBMCs; increased number of regulatory T cells |
Comparison of root formation-related dental MSCs in immature permanent teeth.
DPSCs, dental pulp stem cells; SHED, stem cells of human exfoliated deciduous teeth; SCAP, stem cells from apical papilla; PDLSCs, periodontal ligament stem cells; DFSCs, dental follicle stem cells; HFG, hepatocyte growth factor; IDO, indole amine 2,3-dioxygenase; IFN, interferon; IL, interleukin; PGE2, prostaglandin E2; TGF-β, transforming growth factor beta; Th17, T-helper 17; TLR, Toll-like receptor; PBMCs, peripheral blood mononuclear cells.
DPSCs
Dental pulp tissue, formed by neural crest–derived dental papilla, is the soft tissue surrounded by the dentin. Responding to external stimuli, odontoblasts form the tertiary dentin. These odontoblasts are supposed to be derived from the progenitor cell populations within dental pulp. DPSCs, first isolated from adult third molar pulp tissues by Gronthos et al., possess definitive MSC characteristics, self-renewal capacity, and multilineage differentiation potential (). DPSCs can differentiate into osteoblast-like cells with specific markers, forming new bone in vivo (). A series of case reports indicate the potential application of DPSCs in treating intraosseous defects. In these patients with such defects caused by periodontitis, minimally invasive flap and collagen sponge integrated with autologous/allogeneic DPSCs have been applied. Results showed decreased probing depth reduction, achievement of clinical attachment, and formation of new bone with rare adverse effects, indicating the periodontal tissue regeneration potential of DPSCs (; ; ). DPSCs are known to differentiate into odontoblasts that are indispensable for dentinogenesis. Dentin-like tissue is formed in vivo with DPSCs and hydroxyapatite/tricalcium phosphate (HA/TCP) scaffold, presenting a lining odontoblast-like cell layer of a specific odontoblastic-related marker expression, dentin sialophosphoprotein (DSPP) (; ). Compared with human bone marrow MSCs, DPSCs exhibit notable neurogenic potential due to their origin of the neural crest and could differentiate into neurons upon specific differentiation induction (). The neurogenic potential was also confirmed with higher expression levels of neurotrophins when DPSCs were cocultured with trigeminal neurons (; ). DPSCs also display angiogenic potential for differentiation potential of endothelial cells and the formation of blood vessels after in vivo transplantation with HA scaffold (). A clinical study shows that implanted DPSCs achieve pulp-like tissue regeneration with vasculature and innervation in the root canal of traumatized incisors (). The potential application of DPSCs in dental pulp tissue regeneration has also been indicated by another case report. The affected mature permanent tooth with symptomatic irreversible pulpitis shows a positive response in pulp vitality test, following the administration of autologous DPSCs and leukocyte PRF in the root canal of the affected tooth (). The promising neurogenic, angiogenic, and odontoblastic differentiation potential makes DPSCs a major contributor to dentin regeneration and even whole pulp regeneration.
SHED
SHED were collected from children’s exfoliated deciduous teeth with a similar methodology as that for DPSCs (). SHED possess multilineage differentiation potential and can differentiate into various cell types, such as odontoblasts, adipocytes, and neurons (). However, SHED show capacities of higher proliferation, more cell population doublings, and remarkable osteoinduction compared with DPSCs based on developmental differences between deciduous and permanent teeth. Regenerated new bone with larger osteoids and more collagen fibers by SHED with a polylactic-coglycolic acid membrane suggests that SHED exhibit outstanding potential for bone regeneration compared with DPSCs and bone marrow MSCs (; ). As for the potential of neural regeneration, SHED show more intensive expression of neural differentiation markers than DPSCs under neural induction culture, such as β-III-tubulin and nestin (Wang et al., 2009) and can also promote neural functional recovery (). The odontoblastic differentiation capacity of SHED has been confirmed by in vivo transplantation that the composites of SHED and HA/TCP form a dentin-like structure containing DPSS-positive odontoblasts (). SHED are also capable of forming functional dental pulp tissue, containing odontoblasts to regenerate tubular dentin in full-length root canals combined with collagen type I (). The abovementioned odontoblastic differentiation capacity renders SHED a promising cell source for dentin or pulp regeneration; and whole dental pulp regeneration has been achieved by SHED (Xuan et al., 2018).
SCAP
In the process of tooth development, dental papilla forms dental pulp and migrates apically (Sonoyama et al., 2007b). Several clinical case reports show that root formation continues in some necrotic immature permanent teeth, indicating that MSCs in apical papilla contribute to root development. SCAP are obtained from apical papilla of immature tooth roots and exhibit MSC properties, including expression of MSC surface markers and differentiation potential to a wide variety of cell types (Sonoyama et al., 2006, 2007a). SCAP possess neural differentiation potential similar to DPSCs and SHED, partially attributed to their common origin from the neural crest, and could be an alternative future therapy for spinal cord injury (). Interestingly, SCAP have higher proliferation and greater odontoblastic differentiation potential than DPSCs, suggesting their potential applications for dentin regeneration (Sonoyama et al., 2006). In vivo studies show that SCAP are able to differentiate into odontoblast-like cells and generate dentin-like tissue with DSP expression (Sonoyama et al., 2006, 2007a). The dentin regeneration capacity of SCAP via cell homing strategy is enhanced by their greater migration ability following a scratch assay. SCAP can also form ectopic vascularized pulp-like tissue with DSPP and dentin matrix protein 1 (DMP1)- positive odontoblasts in mouse molars without exogenous growth factor application (). Owing to their critical role in root development, SCAP are supposed to make a major contribution to root regeneration. After transplantation of SCAP and PDLSCs into a minipig model with a lower incisor extracted, a functional bioroot with root/periodontal–like complex was formed. Mineralized root-like tissue is able to support a porcelain crown and perform normal tooth function (Sonoyama et al., 2006).
PDLSCs
A population of MSCs exists in the periodontal ligament (PDL), and it is responsible for periodontal tissue homeostasis and regeneration (; Seo et al., 2004). These cells were first isolated from the PDL of third molars and named PDLSCs. The cementogenic/osteogenic differentiation potential is indicated by the formation of mineralization nodules with the expression of bone-specific markers after in vivo transplantation (Seo et al., 2004). The cementogenic/osteogenic differentiation potential and PDL tissue regeneration potential of PDLSCs are shown in a rat model of periodontal lesions, confirmed by newly formed cementum/PDL-like structures at the lesion area, such as Sharpey’s fiber-like tissue (Seo et al., 2004; ). A recent preclinical study using a novel cell transfer technology demonstrates the potential of PDLSCs in periodontal regeneration. In a rat model of surgical periodontal defects, the transplantation of PDLSC-amniotic membrane composite enhanced the periodontal defect recovery, manifested as newly formed PDL, bone, and cementum at surgically defective sites ().
DFSCs
Dental follicle contributes to alveolar bone formation during tooth development, and contains an MSC population to form supporting tissues, named DFSCs. DFSCs were separated from the dental follicle of developing teeth (; ; Zhou et al., 2019). Compared with DPSCs, SHED, and PDLSCs, DFSCs show a higher proliferation and colony-forming capacity, indicating their application potential in regenerative medicine (Tian et al., 2015; Yildirim et al., 2016). DFSCs also exhibit superior osteogenic properties compared with DPSCs and SHED as shown by the higher expression levels of osteogenic genes (Yildirim et al., 2016). Under the administration of differentiation induction culture medium, DFSCs form osteoblasts and produce mineralized nodules with osteogenic differentiation marker expression, bone sialoprotein, and osteocalcin (; ). DFSCs are capable of periodontal differentiation, indicated by the formation of PDL-like tissues or mineralized structures with bone- or cementum-like tissues (; ). DFSCs generate complex tissues similar to cementum-PDL complex in vivo, in which PDL-like collagen fibers are inserted into newly formed cementum-like tissue (). The potential of odontoblastic differentiation has also been suggested in DFSCs because they have been shown to express higher level of DSPP compared with PDLSCs. The formation of dentin, including dentin, predentin, and calcospherites, is observed with treated dentin matrix induction (Trubiani et al., 2019). All these findings suggest DFSCs as promising seed cells for both dentin and root regeneration.
Cell-Free REPs
Roles of Dental MSCs in Cell-Free REPs
The first attempt at dental pulp tissue regeneration was proposed by Nygaard-Otsby et al. (; ). Over-instrumentation was applied to introduce blood from the periapical tissues into the root canal, followed by tissue growth. Later, proposed a protocol termed revascularization based on the experiments of on implanted teeth, on root canal disinfection, and () on blood clots in the canal space.
The standard REP protocol proposed by the ; ) involves a multistep procedure. The first visit focuses on infection control of the affected tooth with the administration of a proper access cavity, canal irrigation, and disinfection. The common root canal dressing is calcium hydroxide or triple antibiotic paste (TAP), which is a mixture of ciprofloxacin, metronidazole, and minocycline. The second appointment aims to form the suitable scaffold formation for fresh tissue ingrowth and permanent coronal restoration following the absence of clinical signs and symptoms. During this appointment, the root canal is thoroughly irrigated with ethylenediaminetetraacetic acid to release the growth factor from the dentin. Apical bleeding is then stimulated by gentle irritation with a precurved K-file at 2 mm past the apical foramen to form a blood clot in the root canal. Finally, capping material, usually MTA, is placed over the blood clot, followed by the permanent coronal seal to prevent bacterial reinfection. At the follow-up, eliminating clinical signs and symptoms and healing periapical lesion are considered as primary goal of REPs. It is desirable, but not essential, that REPs increase the thickness of the root wall and/or length of the roots, which is the secondary goal. Some cases report that the teeth showed a positive response to pulp vitality testing, suggesting organized pulp tissue in the root canal, which achieves the tertiary goal.
As an amelioration to revascularization with blood clots, the cell homing strategy has been proposed to regenerate dental tissue via a cell-free strategy in which molecules encourage recruitment of the patient’s endogenous MSCs to the root-canal space (; Yin et al., 2017). Several endodontists believe that cell homing is conducive to achieving a more effective strategy of pulp–dentin regeneration than simple revascularization without exogenous cell transplantation (Table 2). Several molecules, including basic fibroblast growth factors, vascular endothelial growth factors, platelet-derived growth factors, nerve growth factors, and bone morphogenetic protein 7, have been applied as homing factors, showing promising outcomes in preclinical studies (). These REPs without exogenous cell transplantation, including revascularization and cell homing, are considered cell-free REPs. Survival rates of cell-free REPs are reported close to 100% in some studies. Therefore, these studies suggest that cell-free REPs have an obvious therapeutic effect on necrotic immature teeth (Figure 2A).
TABLE 2
| Study/year | Sample size (teeth) | Animal model | Intracanal medication | Scaffold | Capping material | Observation period | Results or outcomes |
| Preclinical studies | |||||||
| 40 | Dogs | TAP | Empty scaffold | MTA | 90 days | Hard tissue barrier, and increase of apical periodontal ligament thickness | |
| Yamauchi et al., 2010 | 64 | Dogs | TAP | Cross-linked collagen scaffold + blood clot, blood clot | MTA | 3.5 months | Periapical healing and root wall thickening |
| Tawfik et al., 2013 | 108 | Dogs | TAP | bFGF injectable scaffold + blood clot, blood clot | MTA | 3 months | Negative results in this study: no change of root length and root thickness. |
| 36 | Dogs | TAP | Blood clot | MTA | 3-6 months | periapical healing, apical closure, and dentinal walls thickening | |
| Yoo et al., 2014 | 30 | Dogs | TAP | a collagen scaffold sponge (soaked with conditioned media from mouse preameloblasts) + blood clot | MTA | 12 weeks | Continuous growth of root dentin, and hard tissue formation |
| Zhang et al., 2014 | 27 | Dogs | TAP | PRP, blood blot | MTA | 3 months | Root canal walls thickening, and apical closure |
| 20 | Dogs | TAP | Gelatin-based scaffold (Gelfoam) + blood clot, blood clot | MTA | 7 months | Increase in root length | |
| 40 | Dogs | modified triple-antibiotics paste (mTAP) | PRP, blood blot | MTA | 6 months | Root dentinal walls thickening, hard tissue deposition on dentinal walls, and apical closure | |
| Saoud et al., 2015 | 17 | Dogs | TAP | Blood clot | MTA | 3 months | Not reported about root development and apical closure; but significant dentinal walls thickening, and periapical healing |
| Torabinejad et al., 2015 | 24 | Dogs | TAP | Blood clot/Gelfoam, PRP | MTA | 3 months | Apical narrowing, and hard tissue deposition in the apical third of the root |
| 4 | Sheep | TAP | Blood clot | MTA | 6 months | Significant increases in root length, root wall thickness and narrowing of root canal apical diameter | |
| Study/year | Sample size (teeth) | Age of patients (mean ± SD) | Intracanal medication | Scaffold | Capping material | Observation period (mean ± SD) | Results or outcomes |
| Clinical studies | |||||||
| 2 | 11 years old | TAP | Blood clot | MTA | 18 months | Significant root development with maturation of the dentin | |
| 88 | - | TAP, Ca(OH)2, and formocresol | Blood clot | MTA | 6 months-36 months | Continued root development: increased percentage of root length and dentinal wall thickness | |
| 12 | 8–11 years old | TAP | Blood clot | MTA | 15 months | 3 teeth of 12 exhibit complete root development with closed apex and positive response to electric pulp testing | |
| 6 | 6, 11, and 13 years old | TAP | Blood clot | MTA | 6-12 months | 3 of 6 teeth showed continued root development, and 2 teeth displayed positive response to vitality testing | |
| 1 | 7 years old | Ca(OH)2 paste (Vitapex) | Empty scaffold | Gutta-percha | 30 months | Continued root development, root apex closure, and root canal thickness increase | |
| Thomson and Kahler, 2010 | 1 | 12 years old | TAP | Blood clot | MTA | 18 months | Continued root maturation and apical closure |
| Torabinejad and Turman, 2010 | 1 | 11 years old | TAP | PRP | MTA | 5.5 months | Periapical lesion resolution, further root development, and continued apical closure of the root apex |
| 20 | 8-13 years old | Ca(OH)2 | Blood clot | MTA | 6-26 months | periapical wound healing, and Increased thickening of root canal walls; 15 of 20 teeth continued root development; 4 of 20 teeth exhibited severe hard tissue calcification in pulp canal; 2 of 20 teeth formed a hard tissue barrier in root canal space | |
| 2 | 8, and 9 years old | TAP | Blood clot | Calcium enriched mixture (CEM) | 15-18 months | Periapical radiolucent lesions healing, and continued roots development | |
| 20 | 8-24 years old | TAP | Blood clot | MTA | 21.15 ± 11.70 months | Increased percentage of root width and root length | |
| 3 | 10 and 12 years old | TAP | Blood clot | MTA | 24, 42, and 48 months | Periapical radiolucency disappeared, and root wall thickness increased | |
| 1 | 9 years old | TAP | PRP + Blood clot | MTA | 2 years and 1 months | Resolution of apical periodontitis; hard tissue of obliteration in distal canal, reduction in size of mesial canal space | |
| 6 | 10, 13, and 23 years old | TAP | PRP + blood clot, blood clot | Resin modified glass ionomer cement | 12 months | Periapical healing, apical closure, and dentinal wall thickening | |
| 16 | 7-12 years old | TAP | Blood clot | MTA | 18 months | Patterns of continued root maturogenesis were variable: 90.3% resolution of the periapical radiolucency, 47.2% incomplete apical closure, 19.4% complete apical closure, 2.7% to 25.3% change of root length, and 1.9% to 72.6% change of root dentin thickness | |
| 36 | 9-13 years old | TAP | FGF + blood clot, blood clot | MTA | 18 months – 3 years | Periapical healing, increase in root length and width, and a decrease in apical diameter | |
| Shimizu et al., 2013 | 1 | 9 years old | Ca(OH)2 | Blood clot | MTA | 26 months | Resolution of periapical lesion, continued root development, thickening of the canal walls |
| Sönmez et al., 2013 | 3 | 9 years old | TAP | Blood clot | MTA | 24 months | Continued thickening of the dentinal walls with apical closure; complete resolution of periapical radiolucencies |
| 31 | 6-16 years old | TAP, BAP, Ca(OH)2 | Blood clot | MTA | 14.5 ± 8.5 months | Apical closure and hard tissue barrier; but a greater incidence of adverse events in revascularization group | |
| 22 | 7–13 years old | TAP | PRP, blood clot | MTA | 18 months | Complete apical closure, periapical tissue pathology resolution | |
| 23 | 7-17 years old | TAP, Ca(OH)2, and chlorhexidine | Blood clot | MTA | 9-19 months | Periapical repair, apical closure, root length increase, dentinal walls thickening; but crown discoloration in teeth of TAP group | |
| Saoud et al., 2014 | 20 | 11.3 ± 1.9 years old | TAP | Blood clot | MTA | 1 year | Increase in radiographic root width and length and decrease in apical diameter |
| 20 | Below 20 years old | TAP | RPF + blood clot, PRP + collagen, blood clot | Resin-modified glass ionomer cement | 6-18 months | PRF shows significant periapical healing, apical closure, root lengthening, and dentinal wall thickening in revascularization treatment | |
| 2 | 9, 10 years old | TAP | Blood clot | MTA | 4 months | Progression of root development and maturation of the roots | |
| Timmerman and Parashos, 2016 | 1 | 16 years old | Ca(OH)2 | Blood clot | MTA | 3 years | Complete periapical healing, thickening of the dentinal root walls, and completed apex formation |
| 2 | 8, and 10 years old | BAP, Ca(OH)2 | Blood clot + CollaPlug | MTA | 43-54 months | Complete healing of periapical tissues, continued root development, root length increase, and dentin thickness increase | |
| 1 | 7 years old | Ca(OH)2 | Blood clot | Micro Mega- MTA (MM-MTA) | 2 years | Complete apical healing, continued root growth, and apical closure | |
| 26 | 8-14 years old | TAP | PRP, blood clot | MTA | 12 months | Significant increase in root length, root width, and decrease in apical diameter of PRP-treated teeth compared with blood clot group; but higher amount of crown discoloration in blood clot-treated teeth | |
| 1 | 8 years old | Ca(OH)2, TAP | Blood clot | MTA | 24 months | Periapical healing with increased root thickness and length, and complete apical closure | |
Current preclinical and clinical studies of cell-free REPs.
BAP, bi-antibiotics paste; bFGF, basic fibroblast growth factor; Ca(OH)2, calcium hydroxide; MTA, mineral trioxide aggregate; PRF, platelet-rich fibrin; PRP, platelet-rich plasma; TAP, triple-antibiotics paste.
FIGURE 2
Stem cells, homing to the injury site, have an essential role in wound healing (Rustad and Gurtner, 2011). The cells in the sites of injury and inflammation release chemokines, stem cell factors, and growth factors, which motivate the cell homing (). CXCR4+ SCAP are demonstrated to be chemoattracted by stromal derived factor 1, a chemokine, and migrate into a scaffold made of collagen gel (). In cell-free REPs, stem cells from the periapical tissues get into the root canal space in various ways, mainly by periapical bleeding and molecules in the scaffolds. It is demonstrated that a large number of MSCs with expression of CD105, CD73, and STRO1 were induced into the empty root canal by importing periapical bleeding (). These cells were supposed to be MSCs from the adjacent apical papilla rather than systemic circulation although no direct evidence is shown in that study. Additionally, histological and immunohistochemical analysis presented the formation of cementum- and bone-like structures in necrotic immature permanent teeth with cell-free REPs. It suggests that stem/progenitor cells in periapical tissue, responsible for production of cementum and bone, also entered the root canal and participated in the formation of mineralized tissue during continued root formation (; Shimizu et al., 2012, 2013; Torabinejad and Faras, 2012; ; ). Therefore, undifferentiated MSCs originated from apical papilla, and periapical tissues are considered to be major cell sources for continued root formation and pulp–dentin regeneration. Cells from distant site, such as systemic circulation, are considered to be cell sources for cell-free REPs. However, these cells make little contribution to pulp regeneration, considering their small numbers.
Limitations of Cell-Free REPs
Although cell-free REPs are suggested to be effective in eliminating apical periodontitis and even revitalization of non-vital immature teeth in some case reports, their outcomes are still unpredictable. Elimination of apical periodontitis associated with necrotic immature permanent teeth, the primary goal of REPs, can be easily achieved once the infection in the root canal is controlled with disinfection. However, the vitality of cells in apical papilla, dental follicle, and HERS is determined by severity, origin, and duration of inflammation from immature permanent teeth with pulpal necrosis, which is beyond the control of the endodontists. Once severe damage happens to the apical papilla or follicle, there are no dental MSCs supporting odontoblast differentiation or dentin formation, which results in a lack of continued root formation (Figure 3). It is impossible to clearly define the status of MSCs in the apical papilla and dental follicle; thus, endodontists in the clinic always fail to predict the outcomes of cell-free REPs in the necrotic immature permanent teeth.
FIGURE 3
has defined REPs as “biologically based procedures designed to physiologically replace damaged tooth structures, including dentine and root structures, as well as cells of the pulp –dentin complex.” This suggests that endogenous stem cells introduced by periapical bleeding might achieve pulp–dentin regeneration, which produce odontoblast-like cells and form dentin. However, both animal and preclinical studies fail to show such results. Formation of bone, cementum, and fibrous tissue is observed with revascularization in dogs. The regeneration of the pulp–dentin complex is rarely detected in the root canal. Additionally, histological studies of human teeth present similar cementum apposition, ectopic bone, and fibrous tissues in human mandibular molars treated with revascularization (Torabinejad and Faras, 2012; ). Only one human study shows regenerated pulp–dentin complex with odontoblast-like cells and dentin-like tissue in necrotic immature permanent teeth with cell-free REPs, which is assigned to survival of odontoblasts in the root canal (). These studies suggest that the cell-free REPs of necrotic immature permanent teeth are “repair” rather than “regeneration” procedures (). Unlike immature teeth with pulpal necrosis, teeth with reversible or irreversible pulpitis can regenerate pulp–dentin complex after cell-free REPs. This might result from the remaining pulp tissue, which means the presence of MSCs responsible for pulp–dentin complex is indispensable for true regeneration in endodontics.
Cell-Based REPs
Roles of Dental MSCs in Cell-Based REPs
achieved cell-based pulp regeneration by applying pulp cells and polyglycolic acid in vitro as early as 1996. In 2005, stem cells were introduced as one of the essential elements of pulp–dentin regeneration in endodontics by . Soon afterward, proposed regenerative endodontics as biologically based procedures, in which stem cells play a vital role. Since then, some studies demonstrate the effectiveness of cultured stem cell transplantation in pulp–dentin regeneration (Table 3). reported that MSC transplantation regenerated pulp–dentin complex in human root fragments compared with formation of fibrous tissue with scaffold alone, which was the first in vivo study of pulp–dentin regeneration. Pulp–dentin complex, a layer of odontoblast-like cells on nascent mineralized tissue, is observed in dental MSC–transplanted human dentin with polylactic acid, suggesting a requirement for cell transplantation in pulp–dentin regeneration (Sakai et al., 2010). Later, the necessity of cell transplantation was confirmed with animal studies. Pulp–dentin complex regeneration in large animals was first reported by in a pulpotomy model in dogs, in which fractionated side-population cells enriched with CD31–/CD146– were transplanted. They also indicate that pulp tissue is regenerated in the root canal with a combination of CD105+ DPSCs and SDF-1 (). SDF-1 is considered an important homing signal by recruiting MSCs to injury sites and facilitating regeneration in various tissues (Suzuki et al., 2011). However, pulp tissue is hardly detected in the root canal with SDF-1 alone. These studies further demonstrate that homing signaling alone is insufficient for pulp–dentin regeneration. The transplantation of pulpal MSCs into the root canal is necessary for pulp–dentin regeneration (Figure 2B).
TABLE 3
| Study/year | Type of dental MSCs | Experiment design | Results or outcomes | ||||||
| Animal model | Defects | Route of administration | Biomaterial/scaffold | Growth factors | Observation period | Tissue regeneration | Effect evaluation and safety assessment | ||
| Preclinical studies | |||||||||
| CD 105 + canine DPSCs | 60 incisors; 15 dogs | whole pulp removal; enlargement of apical foramen to 0.7 mm | Autologous transplantation; root canal | Mixture of collagen type I & III | Stromal cell-derived factor-1 (SDF-1) | 14-90 days | Functional dental pulp | HE: regenerative pulp with well vasculature and innervation on day 14 | |
| Canine DPSCs | 72 incisors; 18 dogs | The whole pulp tissue was removed, and the root canals were enlarged to open the apical foramen to 0.6mmin width in incisors | Autologous transplantation; root canal | Atelocollagen scaffold | Granulocyte-colony stimulating factor (G-CSF) | 14-180 days | Functional dental pulp | Safety: no adverse effects on both the whole and local HE: regenerative pulp with well vasculature and innervation on day 14 RG: complete obliteration of the enlarged apical portion and lateral and coronal dentin formation Laser Doppler: functional recovery of pulpal blood flow after 90 days Pulp vitality: positive response on day 60 and day 180 | |
| canine mobilized DPSCs | 16 incisors; 4 dogs | Whole pulp removed, apical foramen enlarged to 0.5 mm | Autologous transplantation; root canal | Atelocollagen scaffold | Granulocyte-colony stimulating factor (G-CSF) | 14-120 days | Functional dental pulp | HE: regenerative pulp with well vasculature and innervation on day 14 RG: complete obliteration of the enlarged apical portion and lateral and coronal dentin formation | |
| Canine mobilized DPSCs | - | Root canals after pulpectomy | Autologous transplantation; root canal | Drug-approved collagen | Granulocyte-colony stimulating factor (G-CSF) | 14-180 days | Pulp-like tissue | Safety: no adverse effects, no inflammatory cells infiltrated, and no internal or external resorption of the tooth HE: pulplike tissue with well vasculature and innervation was regenerated 14 days RG: complete obliteration of the enlarged apical portion and lateral and coronal dentin formation | |
| Canine DPSCs | 36 incisors; 12 dogs | Pulps from crown and root | Autologous transplantation; root canal | Chitosan hydrogel scaffold | Vascular endothelial growth factor (VEGF-2), basic fibroblast growth factor (bFGF), platelet-derived growth factor (PDGF), nerve growth factor (NGF), bone Morphogenetic protein-7 (BMP7) | 1-4 months | Vascularized pulp- dentin like tissue | HE: delicate fibrous tissue resembling the pulp tissue inside the root canal containing multiple large and small blood vessels; newly formed dentin-like tissue with dentinal tubule-like structures along the dentinal walls of the root canal; the regenerated dentin-like tissue did not form well-organized dentinal tubules RGE: closure of the root apex, thickening of the root canal wall, and prolongation of the root lengthening | |
| Xuan et al., 2018 | Pig DPSCs | minipigs | Empty root canals after pulpectomy | DPSC aggregates; autologous transplantation; root canals | - | - | 3 months | Whole pulp tissue | HE: regenerated pulp tissue containing an odontoblast layer and blood vessels IHC: NeuN |
| Study/year | Type of dental MSCs | Experiment design | Results or outcomes | ||||||
| No. of subjects (teeth) | Defects | Route of administration | Biomaterial/scaffold | Growth factors | Observation period | Tissue regeneration | Effect evaluation and safety assessment | ||
| Clinical studies | |||||||||
| Human mobilized DPSCs | 5 teeth (2 incisors, 3 premolars); 5 patients with irreversible pulpitis | Root canals after pulpectomy | Autologous transplantation; root canal | Atelocollagen scaffold | Granulocyte colony-stimulating factor (G-CSF) | 1, 2, 4, 12, and 24/28/32 weeks | Pulp-like tissue | Safety:no adverse events; no postoperative pain, including percussion pain and tenderness; no significant changes in the periapical areas EPT: positive responses after 4 weeks in 4 patients; 1 patient demonstrated a negative response after 24 weeks RG: obliteration of the enlarged apical portion at 24/28 weeks in 3 patients CBCT: lateral dentin formation at 28 weeks in 3 patients MRI: regenerated tissue in the root canal after 24 weeks was similar to that of normal dental pulp in 4 patients | |
| Xuan et al., 2018 | Human DPSCs | 26 incisors; 36 patients | Dental trauma with pulp necrosis | Two hDPSC Aggregates; Autologous implantation; Root canals | - | Extracellular matrix | 1, 3, 6, 9, 12, and 24 months | Whole dental pulp | Safety: no significant side effects after 12 months HE: regeneration of 3D whole dental pulp tissue Digital RVG: no inflammation at the periapical area and continued root development after 24 months EPT: decrease in sensation thresholds CBCT: apical foramen width decreased, the length of the treated tooth root increased Laser Doppler: increase in vascular formation |
Current preclinical and clinical studies of REPs based on dental MSCs.
HE, hematoxylin and eosin staining; IHC, immunohistochemical staining; RG, radiographic examination; RVG, radiovisiography; EPT, electric pulp vitality testing; CBCT, cone beam computed tomography.
In recent years, cell-based REPs have aroused growing concern for pulpless teeth. Several clinical studies demonstrate whole dental pulp regeneration. In a preclinical trial, a composite containing human mobilized DPSCs (MDPSCs) and a collagen scaffold was utilized (). Upon autologous transplantation with the composite into the root canals of canine mature teeth after pulpectomy, vasculature and innervation- regenerated pulp-like tissue was formed with odontoblast-like cells on the surface of the root dentinal wall and newly formed dentin along the dentinal wall. It suggests that complete dental pulp regeneration similar to healthy dental pulp is achieved along with restoration of tooth function. The rarity of adverse events has confirmed the safety of MDPSC-based REPs. The biological characteristics of MDPSCs do not vary with age, including their stability and regenerative potential. Thus, MDPSCs have been applied to a clinical study to further explore the therapeutic potential and clinical safety of autologous MDPSC transplantation in pulpectomized human teeth (). The results show mineralized structure formation of cone beam computed tomography (CBCT), similar signal intensity of magnetic resonance imaging to that of normal dental pulp in untreated controls, robust positive response of a pulp vitality test, and minor adverse events or toxicity. Therefore, human MDPSCs are suggested as safe and efficacious dental MSCs candidates in cell-based REPs.
The therapeutic potential of DPSCs in pulp–dentin regeneration via cell-based REPs is also explored in a minipig pulpectomy model with empty root canals (Xuan et al., 2018). The whole functional pulp tissue regenerates in root canals after implantation of DPSC aggregates harvested from minipigs, consisting of an odontoblast-like layer, blood vessels, and nerves. Based on the preclinical trial with a large animal model, they further conducted a randomized clinical controlled trial to determine the therapeutic effect on immature permanent tooth injuries caused by trauma (Xuan et al., 2018). Those immature necrotic permanent teeth were transplanted autologously with DPSCs collected from primary teeth. Taking apexification as a control group, DPSC-treated immature permanent teeth presented with eliminated apical periodontitis and continued root formation during two years’ follow-up. This was indicated by decreased apical foramen width and increased root length via CBCT, and dentin thickness increased via 3-D reconstruction. The viability of DPSC-treated teeth was validated by laser Doppler flowmetry and electric pulp testing, which showed an increase in vascular formation and decrease in sensation thresholds compared with controls. More excitingly, histological analysis of further traumatized teeth showed regeneration of pulp–dentin complex with an odontoblast layer. Thus, this study demonstrates better efficacy and safety of DPSCs implantation in cell-based REPs, in which 3-D dental pulp tissue with vasculature and innervation was regenerated. Besides, the efficacy and safety of allogenic umbilical cord MSCs have been proved in a preclinical trial (). Other cell populations, such as SCAP or non-dental cells might also be useful in cell-based REPs. Considering the accessibility of cell sources, allogeneic cell sources are more usable.
Challenge for Cell-Based REPs
Cell-based REPs show promising outcomes in pulp–dentin regeneration. Several cell-based REPs are at the stage of clinical studies (; Xuan et al., 2018), but transplantation of stem cells is still not recommended by either the or the European Society of Endodontology (ESE) (). Multiple problems needed to be resolved before clinical application of stem cell transplantation, including isolation of stem cells, expansion of cells in vitro, practice facilities with good manufacturing, skill of clinicians, training of chair-side assistants, and high cost (). MSCs are one of the most important elements in regenerative endodontics. However, their source and potency are still restrained due to the limitation of our available knowledge. In vitro- cultured human somatic stem cells, such as DPSCs, will end up with replicative senescence, a terminal state, after limited cell divisions (). It is suggested that there is a notable elevation of senescent DPSCs cultured in vitro and an obvious reduction of odontogenic differentiation potential that may be attributed to loss of stem cell marker, Bmi1 (). Besides, a large number of cell doublings with homogeneous loss of differentiation potential are required for cell transplantation with ex vivo expansion of DPSCs. Due to the aging-related change in DPSCs in the dental tissue of aged patients, the accessibility of DPSCs suitable for regeneration is restricted to immature permanent teeth of young patients. Therefore, lack of DPSCs from pulp tissue would make cell-based REPs in adult permanent teeth difficult to achieve. The ex vivo expansion of autologous MSCs in dental appointments with high time restrictions requires practice facilities with good manufacturing, and the procedure is always accompanied by high costs. In this context, allogeneic DPSCs may serve as a potential alternative, which can be produced in high volume and manipulated ready for REPs in the clinic. The immunomodulatory effects of allogeneic MSCs are suggested to be of importance in inflammatory disorders. Allogenic umbilical cord MSCs have been used for mature permanent teeth with combination of plasma-derived biomaterials, showing acceptable safety and efficacy in a phase 1/2 clinical trial (). Although transplantation of allogeneic MSCs in REPs shows promising prospects, more research is needed regarding immunogenicity, long-term outcomes, and safety.
Conclusion
Cell-free REPs, including revascularization and cell homing with molecules recruiting endogenous MSCs, are successful in resolving apical periodontitis and arrested root formation, which are eventually clinical regenerative endodontics and widely applied in treating immature permanent teeth with necrotic pulp. However, histological studies show that pulp–dentin complex is absent in these cases although some studies show a positive response to vitality testing. Instead, cell-based REPs with dental MSCs have shown potential with pulp–dentin regeneration in large animal studies and clinical trials through cell transplantation. Before clinical translation of cell-based REPs, more research is still needed regarding isolation of stem cells, expansion of cells in vitro, good practice facilities, skills of clinicians, training of assistants, and reduction of costs. It is hoped that, when cell-based REPs realize true regeneration, they can be applied to the management of necrotic immature permanent teeth, resulting in long-term survival of patients’ natural teeth and dentition.
Statements
Author contributions
DC and MW conceived the idea and designed the work. SY made the figures. XZ, YL, and YP integrated the materials. LZ revised the manuscript. DC wrote the manuscript. MW revised the manuscript critically. All authors have read and approved the final manuscript.
Funding
This work was supported by the National Natural Science Foundation of China (NSFC) Grant 81800929 and Sichuan Science and Technology Program 2019JDRC0096 to MW; National Natural Science Foundation of China (NSFC) Grant 81771033 and Research and Develop Program, West China Hospital of Stomatology Sichuan University, LCYJ2019-24 to LZ.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
1
AimettiM.FerrarottiF.GambaM. N.GiraudiM.RomanoF. (2018). Regenerative treatment of periodontal intrabony defects using autologous dental pulp stem cells: a 1-year follow-up case series.Int. J. Periodontics Restorative Dent.3851–58. 10.11607/prd.3425
2
AjramJ.KhalilI.GergiR.ZogheibC. (2019). Management of an immature necrotic permanent molar with apical periodontitis treated by regenerative endodontic protocol using calcium hydroxide and MM-MTA: a case report with two years follow up.Dent. J.7:1. 10.3390/dj7010001
3
Al AnsaryM. A.DayP. F.DuggalM. S.BruntonP. A. (2009). Interventions for treating traumatized necrotic immature permanent anterior teeth: inducing a calcific barrier & root strengthening.Dent. Traumatol.25367–379. 10.1111/j.1600-9657.2009.00797.x
4
AlasqahM.KhanS. I. R.AlfouzanK.JamlehA. (2020). Regenerative endodontic management of an immature molar using calcium hydroxide and triple antibiotic paste: a two-year follow-up.Case Rep. Dent.2020:9025847. 10.1155/2020/9025847
5
AlobaidA. S.CortesL. M.LoJ.NguyenT. T.AlbertJ.Abu-MelhaA. S.et al (2014). Radiographic and clinical outcomes of the treatment of immature permanent teeth by revascularization or apexification: a pilot retrospective cohort study.J. Endod.401063–1070. 10.1016/j.joen.2014.02.016
6
AltaiiM.CathroP.BrobergM.RichardsL. (2017). Endodontic regeneration and tooth revitalization in immature infected sheep teeth.Int. Endod. J.50480–491. 10.1111/iej.12645
7
American Association of Endodontists [AAE] (2016a). AAE Endodontist’s Glossary of Endodontic Terms. Avaliable at: https://www.aae.org/specialty/clinical-resources/glossary-endodontic-terms(accessed January 5, 2021).
8
American Association of Endodontists [AAE] (2016b). Regenerative Endodontics. Avaliable at: https://www.aae.org/specialty/newsletter/regenerative-endodontics(accessed January 5, 2021).
9
American Association of Endodontists [AAE] (2018). Clinical Considerations for a Regenerative Procedure. Avaliable at: https://www.aae.org/uploadedfiles/publications_and_research/research/currentregenerativeendodonticconsiderations.pdf(accessed January 5, 2021).
10
AndreasenJ. O.BaklandL. K. (2011). Pulp regeneration after non-infected and infected necrosis, what type of tissue do we want? A review.Dent. Traumatol.2813–18. 10.1111/j.1600-9657.2011.01057.x
11
AndreasenJ. O.KristersonI.AndreasenF. M. (1988). Damage of the Hertwig’s epithelial root sheath: effect upon root growth after autotransplantation of teeth in monkeys.Endod. Dent. Traumatol.4145–151. 10.1111/j.1600-9657.1988.tb00313.x
12
AnituaE.TroyaM.ZalduendoM. (2017). Progress in the use of dental pulp stem cells in regenerative medicine.Cytotherapy20479–498. 10.1016/j.jcyt.2017.12.011
13
AustahO.JoonR.FathW. M.ChrepaV.DiogenesA.EzeldeenM.et al (2018). Comprehensive characterization of 2 immature teeth treated with regenerative endodontic procedures.J. Endod.441802–1811. 10.1016/j.joen.2018.09.007
14
BanchsF.TropeM. (2004). Revascularization of immature permanent teeth with apical periodontitis: new treatment protocol?J. Endod.30196–200. 10.1097/00004770-200404000-00003
15
BecerraP.RicucciD.LoghinS.GibbsJ. L.LinL. M. (2013). Histologic study of a human immature permanent premolar with chronic apical abscess after revascularization/revitalization.J. Endod.40133–139. 10.1016/j.joen.2013.07.017
16
BeldiG.BahiraiiS.LezinC.Nouri BarkestaniM.AbdelgawadM. E.UzanG.et al (2020a). TNFR2 is a crucial hub controlling mesenchymal stem cell biological and functional properties.Front. Cell Dev. Biol.8:596831. 10.3389/fcell.2020.596831
17
BeldiG.KhosraviM.AbdelgawadM. E.SalomonB. L.UzanG.HaouasH.et al (2020b). TNFα/TNFR2 signaling pathway: an active immune checkpoint for mesenchymal stem cell immunoregulatory function.Stem Cell Res Ther.11:281. 10.1186/s13287-020-01740-5
18
BezginT.YilmazA. D.CelikB. N.KolsuzM. E.SonmezH. (2014). Efficacy of platelet-rich plasma as a scaffold in regenerative endodontic treatment.J. Endod.4136–44. 10.1016/j.joen.2014.10.004
19
BoseR.NummikoskiP.HargreavesK. (2009). A retrospective evaluation of radiographic outcomes in immature teeth with necrotic root canal systems treated with regenerative endodontic procedures.J. Endod.351343–1349. 10.1016/j.joen.2009.06.021
20
BrizuelaC.MezaG.UrrejolaD.QuezadaM. A.ConchaG.RamírezV.et al (2020). Cell-based regenerative endodontics for treatment of periapical lesions: a randomized, controlled phase i/ii clinical trial.J. Dent. Res.99523–529. 10.1177/0022034520913242
21
ChenM. Y.ChenK. L.ChenC. A.TayebatyF.RosenbergP. A.LinL. M. (2011). Responses of immature permanent teeth with infected necrotic pulp tissue and apical periodontitis/abscess to revascularization procedures.Int. Endod. J.45294–305. 10.1111/j.1365-2591.2011.01978.x
22
CooperP. R.HolderM. J.SmithA. J. (2014). Inflammation and regeneration in the dentin-pulp complex: a double-edged sword.J. Endod.40(4 Suppl.), S46–S51. 10.1016/j.joen.2014.01.021
23
CooperP. R.TakahashiY.GrahamL. W.SimonS.ImazatoS.SmithA. J. (2010). Inflammation-regeneration interplay in the dentin-pulp complex.J. Dent.38687–697. 10.1016/j.jdent.2010.05.016
24
CordeiroM. M.DongZ.KanekoT.ZhangZ.MiyazawaM.ShiS.et al (2008). Dental pulp tissue engineering with stem cells from exfoliated deciduous teeth.J. Endod.34962–969. 10.1016/j.joen.2008.04.009
25
da SilvaG. S.MoreiraM. S.FukushimaK. A.RaggioD. P.V Mello-MouraA. C.LaraJ. S.et al (2019). Current evidence of tissue engineering for dentine regeneration in animal models: a systematic review.Regen. Med.151345–1360. 10.2217/rme-2019-0005
26
da SilvaL. A.Nelson-FilhoP.da SilvaR. A.FloresD. S.HeilbornC.JohnsonJ. D.et al (2009). Revascularization and periapical repair after endodontic treatment using apical negative pressure irrigation versus conventional irrigation plus triantibiotic intracanal dressing in dogs’ teeth with apical periodontitis.Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod.109779–787. 10.1016/j.tripleo.2009.12.046
27
De BerdtP.VanackerJ.UcakarB.ElensL.DiogenesA.LeprinceJ. G.et al (2015). Dental apical papilla as therapy for spinal cord injury.J. Dent. Res.941575–1581. 10.1177/0022034515604612
28
DingR. Y.CheungG. S.ChenJ.YinX. Z.WangQ. Q.ZhangC. F. (2009). Pulp revascularization of immature teeth with apical periodontitis: a clinical study.J. Endod.35745–749. 10.1016/j.joen.2009.02.009
29
DiogenesA.HargeravesK. M. (2017). Microbial modulation of stem cells and future directions in regenerative endodontics.J. Endod.43S95–S101. 10.1016/j.joen.2017.07.012
30
DiogenesA.RuparelN. B.ShiloahY.HargreavesK. M. (2016). Regenerative endodontics: a way forward.J. Am. Dent. Assoc.147372–380. 10.1016/j.adaj.2016.01.009
31
DominiciM.Le BlancK.MuellerI.Slaper-CortenbachI.MariniF.KrauseD.et al (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement.Cytotherapy8315–317. 10.1080/14653240600855905
32
El AshiryE. A.AlamoudiN. M.El AshiryM. K.BastawyH. A.El DerwiD. A.AttaH. M. (2018). Tissue engineering of necrotic dental pulp of immature teeth with apical periodontitis in dogs: radiographic and histological evaluation.J. Clin. Pediatr. Dent.42373–382. 10.17796/1053-4625-42.5.9
33
EramoS.NataliA.PinnaR.MiliaE. (2018). Dental pulp regeneration via cell homing.Int. Endod. J.51405–419. 10.1111/iej.12868
34
FerrarottiF.RomanoF.GambaM. N.QuiricoA.GiraudiM.AudagnaM.et al (2018). Human intrabony defect regeneration with micrografts containing dental pulp stem cells: a randomized controlled clinical trial.J. Clin. Periodontol.45841–850. 10.1111/jcpe.12931
35
GallerK. M.KrastlG.SimonS.Van GorpG.MeschiN.VahediB.et al (2016). European society of endodontology position statement: revitalization procedures.Int. Endod. J.49717–723. 10.1111/iej.12629
36
GronthosS.MankaniM.BrahimJ.RobeyP. G.ShiS. (2000). Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo.Proc, Natl. Acad. Sci. U.S.A.9713625–13630. 10.1073/pnas.240309797
37
HanC.YangZ.ZhouW.JinF.SongY.WangY.et al (2009). Periapical follicle stem cell: a promising candidate for cementum/periodontal ligament regeneration and bio-root engineering.Stem Cells Dev.191405–1415. 10.1089/scd.2009.0277
38
HanY.LiX.ZhangY.HanY.ChangF.DingJ. (2019). Mesenchymal stem cells for regenerative medicine.Cells8:886. 10.3390/cells8080886
39
HeL.ZhongJ.GongQ.ChengB.KimS. G.LingJ.et al (2016). Regenerative endodontics by cell homing.Dent. Clin. North Am.61143–159. 10.1016/j.cden.2016.08.010
40
Hernández-MonjarazB.Santiago-OsorioE.Ledesma-MartínezE.Alcauter-ZavalaA.Mendoza-NúñezV. M. (2018). Retrieval of a periodontally compromised tooth by allogeneic grafting of mesenchymal stem cells from dental pulp: a case report.J. Int. Med. Res.462983–2993. 10.1177/0300060518773244
41
HoshinoE.Kurihara-AndoN.SatoI.UematsuH.SatoM.KotaK.et al (1996). In-vitro antibacterial susceptibility of bacteria taken from infected root dentine to a mixture of ciprofloxacin, metronidazole and minocycline.Int. Endod. J.29125–130. 10.1111/j.1365-2591.1996.tb01173.x
42
HuangG. T.Al-HabibM.GauthierP. (2013). Challenges of stem cell-based pulp and dentin regeneration: a clinical perspective.Endod Top.2851–60. 10.1111/etp.12035
43
HuangG. T.GronthosS.ShiS. (2009a). Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine.J. Dent. Res.88792–806. 10.1177/0022034509340867
44
HuangG. T.YamazaT.SheaL. D.DjouadF.KuhnN. Z.TuanR. S.et al (2010). Stem/progenitor cell-mediated de novo regeneration of dental pulp with newly deposited continuous layer of dentin in an in vivo model.Tissue Eng. Part A16605–615. 10.1089/ten.TEA.2009.0518
45
HuangX.BringasP.Jr.SlavkinH. C.ChaiY. (2009). Fate of HERS during tooth root development.Dev. Biol.33422–30. 10.1016/j.ydbio.2009.06.034
46
IoharaK.ImabayashiK.IshizakaR.WatanabeA.NabekuraJ.ItoM.et al (2010). Complete pulp regeneration after pulpectomy by transplantation of CD105+ stem cells with stromal cell-derived factor-1.Tissue Eng. Part A.171911–1920. 10.1089/ten.TEA.2010.0615
47
IoharaK.MurakamiM.NakataK.NakashimaM. (2014). Age-dependent decline in dental pulp regeneration after pulpectomy in dogs.Exp. Gerontol.5239–45. 10.1016/j.exger.2014.01.020
48
IoharaK.MurakamiM.TakeuchiN.OsakoY.ItoM.IshizakaR.et al (2012). A novel combinatorial therapy with pulp stem cells and granulocyte colony-stimulating factor for total pulp regeneration.Stem Cells Transl. Med.2521–533. 10.5966/sctm.2012-0132
49
IoharaK.ZhengL.ItoM.IshizakaR.NakamuraH.IntoT.et al (2009). Regeneration of dental pulp after pulpotomy by transplantation of CD31(-)/CD146(-) side population cells from a canine tooth.Regen. Med.4377–385. 10.2217/rme.09.5
50
IwasakiK.AkazawaK.NagataM.KomakiM.HondaI.MoriokaC.et al (2019). The fate of transplanted periodontal ligament stem cells in surgically created periodontal defects in rats.Int. J. Mol. Sci.20:192. 10.3390/ijms20010192
51
IwataT.YamatoM.ZhangZ.MukobataS.WashioK.AndoT.et al (2010). Validation of human periodontal ligament-derived cells as a reliable source for cytotherapeutic use.J. Clin, Periodontol.371088–1099. 10.1111/j.1600-051X.2010.01597.x
52
IwayaS.IkawaM.KubotaM. (2001). Revascularization of an immature permanent tooth with apical periodontitis and sinus tract.Dent. Traumatol.17185–187. 10.1034/j.1600-9657.2001.017004185.x
53
IwayaS.IkawaM.KubotaM. (2010). Revascularization of an immature permanent tooth with periradicular abscess after luxation.Dent. Traumatol.2755–58. 10.1111/j.1600-9657.2010.00963.x
54
JadhavG. R.ShahN.LoganiA. (2013). Comparative outcome of revascularization in bilateral, non-vital, immature maxillary anterior teeth supplemented with or without platelet rich plasma: a case series.J. Conserv. Dent.16568–572. 10.4103/0972-0707.120932
55
JeeruphanT.JantaratJ.YanpisetK.SuwannapanL.KhewsawaiP.HargreavesK. M. (2012). Mahidol study 1: comparison of radiographic and survival outcomes of immature teeth treated with either regenerative endodontic or apexification methods: a retrospective study.J. Endod.381330–1336. 10.1016/j.joen.2012.06.028
56
JeongS. Y.LeeS.ChoiW. H.JeeJ. H.KimH. R.YooJ. (2020). Fabrication of dentin-pulp-like organoids using dental-pulp stem cells.Cells9:642. 10.3390/cells9030642
57
JohnsonR. W. (1997). Inhibition of growth by pro-inflammatory cytokines: an integrated view.J. Anim. Sci.751244–1255. 10.2527/1997.7551244x
58
JungJ.KimJ. W.MoonH. J.HongJ. Y.HyunJ. K. (2016). Characterization of neurogenic potential of dental pulp stem cells cultured in xeno/serum-free condition: in vitro and in vivo assessment.Stem Cells Int.2016:6921097. 10.1155/2016/6921097
59
KahlerB.MistryS.MouleA.RingsmuthA. K.CaseP.ThomsonA.et al (2013). Revascularization outcomes: a prospective analysis of 16 consecutive cases.J. Endod.40333–338. 10.1016/j.joen.2013.10.032
60
KangM. K.KametaA.ShinK. H.BaludaM. A.ParkN. H. (2004). Senescence occurs with hTERT repression and limited telomere shortening in human oral keratinocytes cultured with feeder cells.J. Cell Physiol.199364–370. 10.1002/jcp.10410
61
Kawase-KogaY.FujiiY.YamakawaD.SatoM.ChikazuD. (2019). Identification of neurospheres generated from human dental pulp stem cells in xeno-/serum-free conditions.Regen. Ther.14128–135. 10.1016/j.reth.2019.11.006
62
KhademiA. A.DianatO.MahjourF.RazaviS. M.YounessianF. (2014). Outcomes of revascularization treatment in immature dog’s teeth.Dent. Traumatol.30374–379. 10.1111/edt.12100
63
KimD. S.ParkH. J.YeomJ. H.SeoJ. S.RyuG. J.ParkK. H.et al (2012). Long-term follow-ups of revascularized immature necrotic teeth: three case reports.Int. J. Oral. Sci.4109–113. 10.1038/ijos.2012.23
64
KimJ. Y.XinX.MoioliE. K.ChungJ.LeeC. H.ChenM.et al (2010). Regeneration of dental-pulp-like tissue by chemotaxis-induced cell homing.Tissue Eng. Part A.163023–3031. 10.1089/ten.TEA.2010.0181
65
KlingM.CvekM.MejareI. (1986). Rate and predictability of pulp revascularization in therapeutically reimplanted permanent incisors.Endod Dent, Traumatol.283–89. 10.1111/j.1600-9657.1986.tb00132.x
66
KunimatsuR.NakajimaK.AwadaT.TsukaY.AbeT.AndoK.et al (2018). Comparative characterization of stem cells from human exfoliated deciduous teeth, dental pulp, and bone marrow-derived mesenchymal stem cells.Biochem. Biophys, Res. Commun.501193–198. 10.1016/j.bbrc.2018.04.213
67
LiuC.XiongH.ChenK.HuangY.HuangY.YinX. (2016). Long-term exposure to pro-inflammatory cytokines inhibit the osteogenic/dentinogenic differentiation of stem cells from the apical papilla.Int. Endod. J.49950–959. 10.1111/iej.12551
68
LiuJ. Y.ChenX.YueL.HuangG. T.ZouX. Y. (2015). Cxc chemokine receptor 4 is expressed paravascularly in apical papilla and coordinates with stromal cell-derived factor-1alpha during transmigration of stem cells from apical papilla.J. Endod.411430–1436. 10.1016/j.joen.2015.04.006
69
Londero CdeL.PagliarinC. M.FelippeM. C.FelippeW. T.DanesiC. C.BarlettaF. B. (2015). Histologic analysis of the influence of a gelatin-based scaffold in the repair of immature dog teeth subjected to regenerative endodontic treatment.J. Endod.411619–1625. 10.1016/j.joen.2015.01.033
70
LovelaceT. W.HenryM. A.HargreavesK. M.DiogenesA. (2010). Evaluation of the delivery of mesenchymal stem cells into the root canal space of necrotic immature teeth after clinical regenerative endodontic procedure.J. Endod.37133–138. 10.1016/j.joen.2010.10.009
71
MartinG.RicucciD.GibbsJ. L.LinL. M. (2012). Histological findings of revascularized/revitalized immature permanent molar with apical periodontitis using platelet-rich plasma.J. Endod.39138–144. 10.1016/j.joen.2012.09.015
72
McCullochC. A.MelcherA. H. (1983). Cell density and cell generation in the periodontal ligament of mice.Am. J, Anat.16743–58. 10.1002/aja.1001670105
73
MehrazarinS.OhJ. F.ChungC. L.ChenW.KimR. H.ShiS. T.et al (2011). Impaired odontogenic differentiation of senescent dental mesenchymal stem cells is associated with loss of Bmi-1 expression.J. Endod.37662–666. 10.1016/j.joen.2011.02.009
74
MezaG.UrrejolaD.Saint JeanN.InostrozaC.LópezV.KhouryM.et al (2018). Personalized cell therapy for pulpitis using autologous dental pulp stem cells and leukocyte platelet-rich fibrin: a case report.J. Endod.45144–149. 10.1016/j.joen.2018.11.009
75
MiuraM.GronthosS.ZhaoM.LuB.FisherL. W.RobeyP. G.et al (2003). SHED: stem cells from human exfoliated deciduous teeth.Proc. Natl. Acad. Sci. U.S.A.1005807–5812. 10.1073/pnas.0937635100
76
MooneyD. J.PowellC.PianaJ.RutherfordB. (1996). Engineering dental pulp-like tissue in vitro.Biotechnol. Prog.12865–868. 10.1021/bp960073f
77
MorsczeckC.GötzW.SchierholzJ.ZeilhoferF.KühnU.MöhlC.et al (2004). Isolation of precursor cells (PCs) from human dental follicle of wisdom teeth.Matrix Biol.24155–165. 10.1016/j.matbio.2004.12.004
78
MortadaI.MortadaR. (2018). Dental pulp stem cells and osteogenesis: an update.Cytotechnology701479–1486. 10.1007/s10616-018-0225-5
79
MurrayP. E.Garcia-GodoyF.HargreavesK. M. (2006). Regenerative endodontics: a review of current status and a call for action.J. Endod.33377–390. 10.1016/j.joen.2006.09.013
80
NagataJ. Y.GomesB. P.Rocha LimaT. F.MurakamiL. S.de FariaD. E.CamposG. R.et al (2014). Traumatized immature teeth treated with 2 protocols of pulp revascularization.J. Endod.40606–612. 10.1016/j.joen.2014.01.032
81
NagyM. M.TawfikH. E.HashemA. A.Abu-SeidaA. M. (2013). Regenerative potential of immature permanent teeth with necrotic pulps after different regenerative protocols.J. Endod.40192–198. 10.1016/j.joen.2013.10.027
82
NakashimaM.AkamineA. (2005). The application of tissue engineering to regeneration of pulp and dentin in endodontics.J. Endod.31711–718. 10.1097/01.don.0000164138.49923.e5
83
NakashimaM.IoharaK. (2014). Mobilized dental pulp stem cells for pulp regeneration: initiation of clinical trial.J. Endod.40(4 Suppl.), S26–S32. 10.1016/j.joen.2014.01.020
84
NakashimaM.IoharaK.MurakamiM.NakamuraH.SatoY.ArijiY.et al (2017). Pulp regeneration by transplantation of dental pulp stem cells in pulpitis: a pilot clinical study.Stem Cell Res. Ther.8:61. 10.1186/s13287-017-0506-5
85
NarangI.MittalN.MishraN. (2015). A comparative evaluation of the blood clot, platelet-rich plasma, and platelet-rich fibrin in regeneration of necrotic immature permanent teeth: a clinical study.Contemp. Clin. Dent.663–68. 10.4103/0976-237X.149294
86
NaserianS.AbdelgawadM. E.Afshar BakshlooM.HaG.AroucheN.CohenJ. L.et al (2020). The TNF/TNFR2 signaling pathway is a key regulatory factor in endothelial progenitor cell immunosuppressive effect.Cell Commun. Signal.18:94. 10.1186/s12964-020-00564-3
87
NicolaF.MarquesM. R.OdorcykF.PetenuzzoL.AristimunhaD.VizueteA.et al (2018). Stem cells from human exfoliated deciduous teeth modulate early astrocyte response after spinal cord contusion.Mol. Neurobiol.56748–760. 10.1007/s12035-018-1127-4
88
NicolosoG. F.PötterI. G.RochaR. O.MontagnerF.CasagrandeL. (2017). A comparative evaluation of endodontic treatments for immature necrotic permanent teeth based on clinical and radiographic outcomes: a systematic review and meta-analysis.Int. J. Paediatr. Dent.27217–227. 10.1111/ipd.12261
89
NoronhaN. D. C.MizukamiA.Caliári-OliveiraC.CominalJ. G.RochaJ. L. M.CovasD. T.et al (2019). Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies.Stem Cell Res. Ther.10:131. 10.1186/s13287-019-1224-y
90
NosratA.KolahdouzanA.HosseiniF.MehriziE. A.VermaP.TorabinejadM. (2015). Histologic outcomes of uninfected human immature teeth treated with regenerative endodontics: 2 case reports.J. Endod.411725–1729. 10.1016/j.joen.2015.05.004
91
NosratA.SeifiA.AsgaryS. (2011). Regenerative endodontic treatment (revascularization) for necrotic immature permanent molars: a review and report of two cases with a new biomaterial.J. Endod.37562–567. 10.1016/j.joen.2011.01.011
92
Nygaard-OstbyB. (1961). The role of the blood clot in endodontic therapy. An experimental histologic study.Acta Odontol. Scand.19324–353.
93
Nygaard-OstbyB.HjortdalO. (1971). Tissue formation in the root canal following pulp removal.Scand. J. Dent. Res.79333–349. 10.1111/j.1600-0722.1971.tb02019.x
94
PagellaP.MiranS.NetoE.MartinI.LamghariM.MitsiadisT. A. (2019). Human dental pulp stem cells exhibit enhanced properties in comparison to human bone marrow stem cells on neurites outgrowth.FASEB J.345499–5511. 10.1096/fj.201902482R
95
PelissariC.ParisA. F. C.MantessoA.TrierveilerM. (2018). Apical papilla cells are capable of forming a pulplike tissue with odontoblastlike cells without the use of exogenous growth factors.J. Endod.441671–1676. 10.1016/j.joen.2018.08.005
96
PetrinoJ. A.BodaK. K.ShambargerS.BowlesW. R.McClanahanS. B. (2009). Challenges in regenerative endodontics: a case series.J. Endod.36536–541. 10.1016/j.joen.2009.10.006
97
PittengerM. F.MackayA. M.BeckS. C.JaiswalR. K.DouglasR.MoscaJ. D. (1999). Multilineage potential of adult human mesenchymal stem cells.Science284143–147. 10.1126/science.284.5411.143
98
RafterM. (2004). Apexification: a review.Dent. Traumatol.211–8. 10.1111/j.1600-9657.2004.00284.x
99
ReynoldsK.JohnsonJ. D.CohencaN. (2008). Pulp revascularization of necrotic bilateral bicuspids using a modified novel technique to eliminate potential coronal discolouration: a case report.Int. Endod. J.4284–92. 10.1111/j.1365-2591.2008.01467.x
100
RizkH. M.Al-DeenM. S. S.EmamA. A. (2019). Regenerative endodontic treatment of bilateral necrotic immature permanent maxillary central incisors with platelet-rich plasma versus blood clot: a split mouth double-blinded randomized controlled trial.Int. J. Clin. Pediatr. Dent.12332–339. 10.5005/jp-journals-10005-1656
101
Rodríguez-BenítezS.StambolskyC.Gutiérrez-PérezJ. L.Torres-LagaresD.Segura-EgeaJ. J. (2015). Pulp revascularization of immature dog teeth with apical periodontitis using triantibiotic paste and platelet-rich plasma: a radiographic study.J. Endod.411299–1304. 10.1016/j.joen.2015.05.002
102
RustadK. C.GurtnerG. C. (2011). Mesenchymal stem cells home to sites of injury and inflammation.Adv. Wound Care1147–152. 10.1089/wound.2011.0314
103
SakaiV. T.ZhangZ.DongZ.NeivaK. G.MachadoM. A.ShiS.et al (2010). SHED differentiate into functional odontoblasts and endothelium.J. Dent. Res.89791–796. 10.1177/0022034510368647
104
SaoudT. M.ZaazouA.NabilA.MoussaS.AlyH. M.OkazakiK.et al (2015). Histological observations of pulpal replacement tissue in immature dog teeth after revascularization of infected pulps.Dent. Traumatol.31243–249. 10.1111/edt.12169
105
SaoudT. M.ZaazouA.NabilA.MoussaS.LinL. M.GibbsJ. L. (2014). Clinical and radiographic outcomes of traumatized immature permanent necrotic teeth after revascularization/revitalization therapy.J. Endod.401946–1952. 10.1016/j.joen.2014.08.023
106
SeoB. M.MiuraM.GronthosS.BartoldP. M.BatouliS.BrahimJ.et al (2004). Investigation of multipotent postnatal stem cells from human periodontal ligament.Lancet364149–155. 10.1016/S0140-6736(04)16627-0
107
ShabahangS. (2012). Treatment options: apexogenesis and apexification.J. Endod.39(3 Suppl.), S26–S29. 10.1016/j.joen.2012.11.046
108
SharpeP. T. (2016). Dental mesenchymal stem cells.Development1432273–2280. 10.1242/dev.134189
109
ShimizuE.JongG.PartridgeN.RosenbergP. A.LinL. M. (2012). Histologic observation of a human immature permanent tooth with irreversible pulpitis after revascularization/regeneration procedure.J. Endod.381293–1297. 10.1016/j.joen.2012.06.017
110
ShimizuE.RicucciD.AlbertJ.AlobaidA. S.GibbsJ. L.HuangG. T.et al (2013). Clinical, radiographic, and histological observation of a human immature permanent teeth with chronic apical abscess after revitalization treatment.J. Endod.391078–1083. 10.1016/j.joen.2013.04.032
111
SönmezI. S.Akbay ObaA.Erkmen AlmazM. (2013). Revascularization/Regeneration performed in immature molars: case reports.J. Clin. Pediatr. Dent.37231–234. 10.17796/jcpd.37.3.j6007761g8811453
112
SonoyamaW.LiuY.FangD.YamazaT.SeoB. M.ZhangC.et al (2006). Mesenchymal stem cell-mediated functional tooth regeneration in swine.PLoS One1:e79. 10.1371/journal.pone.0000079
113
SonoyamaW.LiuY.YamazaT.TuanR. S.WangS.ShiS.et al (2007a). Characterization of the apical papilla and its residing stem cells from human immature permanent teeth: a pilot study.J. Endod.34166–171. 10.1016/j.joen.2007.11.021
114
SonoyamaW.SeoB. M.YamazaT.ShiS. (2007b). Human Hertwig’s epithelial root sheath cells play crucial roles in cementum formation.J. Dent. Res.86594–599. 10.1177/154405910708600703
115
SuzukiT.LeeC. H.ChenM.ZhaoW.FuS. Y.QiJ. J.et al (2011). Induced migration of dental pulp stem cells for in vivo pulp regeneration.J. Dent. Res.901013–1018. 10.1177/0022034511408426
116
TawfikH.Abu-SeidaA. M.HashemA. A.NagyM. M. (2013). Regenerative potential following revascularization of immature permanent teeth with necrotic pulps.Int. Endod. J.46910–922. 10.1111/iej.12079
117
ThesleffI.SharpeP. (1997). Signalling networks regulating dental development.Mech. Dev.67111–123. 10.1016/s0925-4773(97)00115-9
118
ThomsonA.KahlerB. (2010). Regenerative endodontics–biologically-based treatment for immature permanent teeth: a case report and review of the literature.Aust. Dent. J.55446–452. 10.1111/j.1834-7819.2010.01268.x
119
TianY.BaiD.GuoW.LiJ.ZengJ.YangL.et al (2015). Comparison of human dental follicle cells and human periodontal ligament cells for dentin tissue regeneration.Regen. Med.10461–479. 10.2217/rme.15.21
120
TimmermanA.ParashosP. (2016). Delayed root development by displaced mineral trioxide aggregate after regenerative endodontics: a case report.J. Endod.43252–256. 10.1016/j.joen.2016.10.024
121
TorabinejadM.FarasH. (2012). A clinical and histological report of a tooth with open apex treated with regenerative endodontics using platelet-rich plasma.J. Endod.38864–868. 10.1016/j.joen.2012.03.006
122
TorabinejadM.MilanM.ShabahangS.WrightK. R.FarasH. (2015). Histologic examination of teeth with necrotic pulps and periapical lesions treated with 2 scaffolds: an animal investigation.J. Endod.41846–852. 10.1016/j.joen.2015.01.026
123
TorabinejadM.TurmanM. (2010). Revitalization of tooth with necrotic pulp and open apex by using platelet-rich plasma: a case report.J. Endod.37265–268. 10.1016/j.joen.2010.11.004
124
TrubianiO.PizzicannellaJ.CaputiS.MarchisioM.MazzonE.PaganelliR.et al (2019). Periodontal ligament stem cells: current knowledge and future perspectives.Stem Cells Dev.28995–1003. 10.1089/scd.2019.0025
125
UlusoyA. T.TurediI.CimenM.CehreliZ. C. (2019). Evaluation of blood clot, platelet-rich plasma, platelet-rich fibrin, and platelet pellet as scaffolds in regenerative endodontic treatment: a prospective randomized trial.J. Endod.45560–566. 10.1016/j.joen.2019.02.002
126
WangF.JiangY.HuangX.LiuQ.ZhangY.LuoW.et al (2017). Pro-inflammatory cytokines TNF-a attenuates BMP9-induced osteo/odontoblasts differentiation of the stem cells of dental apical papilla.Cell Physiol. Biochem.411725–1735. 10.1159/000471865
127
WangJ.WangX.SunZ.WangX.YangH.ShiS.et al (2009). Stem cells from human-exfoliated deciduous teeth can differentiate into dopaminergic neuron-like cells.Stem Cells Dev.191375–1383. 10.1089/scd.2009.0258
128
XuanK.LiB.GuoH.SunW.KouX.HeX.et al (2018). Deciduous autologous tooth stem cells regenerate dental pulp after implantation into injured teeth.Sci. Transl. Med.10:eaaf3227. 10.1126/scitranslmed.aaf3227
129
YamauchiN.YamauchiS.NagaokaH.DugganD.ZhongS.LeeS. M.et al (2010). Tissue engineering strategies for immature teeth with apical periodontitis.J. Endod.37390–397. 10.1016/j.joen.2010.11.010
130
YildirimS.ZibandehN.GencD.OzcanE. M.GokerK.AkkocT. (2016). The comparison of the immunologic properties of stem cells isolated from human exfoliated deciduous teeth, dental pulp, and dental follicles.Stem Cells Int.2016:4682875. 10.1155/2016/4682875
131
YinY.LiX.HeX. T.WuR. X.SunH. H.ChenF. M. (2017). Leveraging stem cell homing for therapeutic regeneration.J. Dent. Res.96601–609. 10.1177/0022034517706070
132
YooY. J.LeeW.ChoY. A.ParkJ. C.ShonW. J.BaekS. H. (2014). Effect of conditioned medium from preameloblasts on regenerative cellular differentiation of the immature teeth with necrotic pulp and apical periodontitis.J. Endod.401355–1361. 10.1016/j.joen.2014.02.009
133
Zeichner-DavidM.OishiK.SuZ.ZakartchenkoV.ChenL. S.ArzateH.et al (2003). Role of Hertwig’s epithelial root sheath cells in tooth root development.Dev. Dyn.228651–663. 10.1002/dvdy.10404
134
ZhangD. D.ChenX.BaoZ. F.ChenM.DingZ. J.ZhongM. (2014). Histologic comparison between platelet-rich plasma and blood clot in regenerative endodontic treatment: an animal study.J. Endod.401388–1393. 10.1016/j.joen.2014.03.020
135
ZhouT.PanJ.WuP.HuangR.DuW.ZhouY.et al (2019). Dental follicle cells: roles in development and beyond.Stem Cells Int.2019:9159605. 10.1155/2019/9159605
Summary
Keywords
dental mesenchymal stem cells, regenerative endodontics, pulp-dentin regeneration, immature permanent teeth, cell transplantation
Citation
Cui D, Yu S, Zhou X, Liu Y, Gan L, Pan Y, Zheng L and Wan M (2021) Roles of Dental Mesenchymal Stem Cells in the Management of Immature Necrotic Permanent Teeth. Front. Cell Dev. Biol. 9:666186. doi: 10.3389/fcell.2021.666186
Received
09 February 2021
Accepted
06 April 2021
Published
19 May 2021
Volume
9 - 2021
Edited by
Takehito Ouchi, Tokyo Dental College, Japan
Reviewed by
Sina Naserian, INSERM UMR-S-MD 1197, Hôpital Paul Brousse, France; Louis Charles Penning, Utrecht University, Netherlands
Updates
Copyright
© 2021 Cui, Yu, Zhou, Liu, Gan, Pan, Zheng and Wan.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Mian Wan, mianwan@scu.edu.cn
This article was submitted to Stem Cell Research, a section of the journal Frontiers in Cell and Developmental Biology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.